Google Ventures

GV is a multi‑stage venture firm that invests across industries with a long‑term orientation—"decades, not rounds." Backed solely by Alphabet, the firm operates autonomously and is financially driven, able to back competitors to Google while giving portfolio companies access to Google talent and technology when useful. Its sector focus spans AI, enterprise, consumer, frontier technology, and life sciences, with roughly 80% of new investments classified as AI‑native. GV maintains a strong life‑sciences practice and looks for ideas that require deep technical differentiation and long‑term capital support. Geographically, GV backs startups in North America, Europe, and Israel, with a dedicated European hub in London and over $1 billion invested in European startups since 2014. The firm’s core belief is that value is created by combining founder empathy, hands‑on company‑building resources (design, engineering, marketing, talent) with selective access to Google’s network. GV targets opportunities that demand multi‑stage relationships and technical moats, while discarding deals where the price does not reflect stage or quality. The firm positions itself as a returns‑first investor rather than a strategic corporate arm, aiming to be a partner of choice irrespective of the eventual acquirer.

GV places founder quality and technical differentiation at the top of its checklist, weighing market size and timing second, and scrutinizing valuation and price‑to‑value ratio as a hard constraint. Tom Hulme emphasizes that the firm invests purely for financial return and is "relaxed" about leading versus joining syndicates, preferring entry into the best companies over ownership rules. The firm passes on AI deals when the value‑to‑price ratio does not work. Internally, partners are empowered to make convictions with few internal blocks; David Krane notes they invest over a billion dollars a year with high volume. Relationship‑driven conviction is evident in examples like the $10 M Series A in Universe, where GV’s partner joined the board. Early‑stage decisions heavily weight team and product potential, while later stages incorporate traction and scalability, but price discipline remains pivotal. GV favors large, durable markets where AI or other frontier tech creates step‑change opportunities and avoids overpaying when stage, price, or quality misalign.

• Blue Water AutonomyLead
  Frontier defense autonomy leveraging AI perception aligns with GV's AI and frontier-tech conviction. GV led the Series A (Dave Munichiello).
• Mechanical OrchardLead
  Enterprise modernization platform with AI-forward software migration. GV led the $50M Series B.
• MetaviewLead
  AI-native hiring platform. GV led the $35M Series B.
• ComplyanceLead
  Agentic AI for governance, risk and compliance. GV led the $20M Series A (Feb 2026).
• SambaNovaLead
  AI infrastructure and hardware venture. GV co-led the 2018 $56M Series A with Walden International.
• EpiBiologicsLead
  Novel extracellular protein degradation platform aligns with GV's life-sciences investment theme.
• AttioLead
  AI-native CRM; GV led Attio's $52M Series B (Aug 2025).
• DriverLead
  AI-driven technical documentation tool accelerates enterprise productivity, fitting GV's AI tooling thesis.
• TranslucentLead
  AI applied to healthcare finance. GV led the $27M Series A (March 2026).
• Guild.aiLead
  Collaborative intelligence platform aligns with GV's AI apps and developer-tools investment theses.

No catalog overlap found yet. Co-investors are derived from each firm's notable investments — connections may surface as more firms are added.